The Skyrocketting Need for Speed: Partnering to develop rapid diagnostic tests that protect patients from antibiotic resistant infections during disasters and every day

In cases where patients are infected with antibiotic resistant infections, a rapid diagnosis can save life or limb – and the need for speed skyrockets during a public health emergency. Find out what BARDA is doing to support fast, accurate diagnostics.

 

The health security threat in my backyard: how my garden proved that the U.S. needs more, rapid, diagnostics for antimicrobial resistant infections

What started as a small cut turned into a serious problem for BARDA Director Rick Bright – and it nearly cost him his thumb. Find out how a small cut and a delayed diagnosis threatened his health and may have endangered hospitalized patients around him.

 

Resolving to Be Ready to Protect Critical Infrastructure

Three Ways for Public Health and Medical Professionals to Enhance Preparedness

When disaster strikes, critical infrastructure failures can keep you from providing effective patient care. ASPR’s Division of Critical Infrastructure Protection (CIP) has built tools, resources, and partnerships to enhance your facility's preparedness.

 

Making history: the world’s first FDA-approved Ebola vaccine

Public-private partners collaborate to prevent the spread of a global health threat

ERVEBO – developed by Merck & supported by BARDA – has become the first Ebola vaccine approved by the FDA. The vaccine has been given to over 255k people under an expanded access protocol in the fight against Ebola in the DRC.